Bal Pharma Ltd
₹67.90
(0.09%)
Wed, 01 Apr 2026, 10:32 am
Bal Pharma Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 50.86 | 50.86 | 50.86 | 50.86 | 50.86 |
| FII | 0.14 | 0.22 | 0.15 | 0.14 | 0.14 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 49.01 | 48.92 | 48.99 | 49.00 | 49.00 |
| Government | 0 | 0 | 0 | 0 | 0 |
Bal Pharma Ltd Shareholding Pattern
The Bal Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Bal Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Bal Pharma Ltd (NSE: BALPHARMA, BSE: 524824) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Bal Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Bal Pharma Ltd Shareholding Pattern (Latest)
The latest Bal Pharma Ltd shareholding for Dec 2025 is:
- Promoters: 50.86%
- FII: 0.14%
- DII: 0%
- Public: 49.01%
- Government: 0%
Promoter holding in Bal Pharma Ltd remains stable, reflecting consistent long-term commitment.
Bal Pharma Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Bal Pharma Ltd.
- Dec 2025: 50.86%
- Sept 2025: 50.86%
- Jun 2025: 50.86%
- Mar 2025: 50.86%
- Dec 2024: 50.86%
Promoter stake remains largely stable, showing consistent ownership structure.
Bal Pharma Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Bal Pharma Ltd.
- Dec 2025: 0.14%
- Sept 2025: 0.22%
- Jun 2025: 0.15%
- Mar 2025: 0.14%
- Dec 2024: 0.14%
FII holding has declined, suggesting cautious sentiment among foreign investors.
Bal Pharma Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Dec 2025: 0%
- Sept 2025: 0%
- Jun 2025: 0%
- Mar 2025: 0%
- Dec 2024: 0%
DII holdings remain stable, reflecting steady institutional participation.
Bal Pharma Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Dec 2025: 49.01%
- Sept 2025: 48.92%
- Jun 2025: 48.99%
- Mar 2025: 49.00%
- Dec 2024: 49.00%
Public participation in Bal Pharma Ltd has increased, indicating rising retail investor interest.
Bal Pharma Ltd Government Holding
Government holding in Bal Pharma Ltd currently stands at 0%.
Bal Pharma Ltd operates without significant government ownership.
Bal Pharma Ltd Shareholding Analysis Summary
The Bal Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Bal Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Bal Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800